Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$58.92
+0.0%
$65.32
$54.48
$94.93
$7.98B1.21.40 million shs366,345 shs
Integer Holdings Co. stock logo
ITGR
Integer
$118.71
+0.3%
$119.43
$104.93
$146.36
$4.14B0.98376,629 shs71,453 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$120.80
+0.7%
$126.73
$118.70
$249.91
$5.34B1.1626,301 shs73,390 shs
Synthorx, Inc. stock logo
THOR
Synthorx
$67.99
$67.99
$11.05
$71.90
$2.20BN/A474,507 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.00%-1.73%-3.98%-18.45%-10.30%
Integer Holdings Co. stock logo
ITGR
Integer
0.00%-2.58%-2.42%-0.95%+1.56%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%-2.24%-7.14%-14.09%-42.42%
Synthorx, Inc. stock logo
THOR
Synthorx
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.7649 of 5 stars
4.33.00.04.12.02.51.9
Integer Holdings Co. stock logo
ITGR
Integer
3.2366 of 5 stars
3.54.00.00.01.52.51.3
Teleflex Incorporated stock logo
TFX
Teleflex
4.733 of 5 stars
3.04.02.53.91.61.72.5
Synthorx, Inc. stock logo
THOR
Synthorx
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.62
Moderate Buy$94.0059.54% Upside
Integer Holdings Co. stock logo
ITGR
Integer
3.00
Buy$145.0022.14% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.09
Hold$164.6336.28% Upside
Synthorx, Inc. stock logo
THOR
Synthorx
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest THOR, GMED, TFX, and ITGR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/10/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/27/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
5/27/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
5/22/2025
Integer Holdings Co. stock logo
ITGR
Integer
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy$133.00 ➝ $140.00
5/12/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$80.00 ➝ $68.00
5/9/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $80.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$140.00 ➝ $137.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$191.00 ➝ $173.00
5/2/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$150.00 ➝ $145.00
5/2/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$146.00 ➝ $137.00
4/25/2025
Integer Holdings Co. stock logo
ITGR
Integer
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$140.00 ➝ $150.00
(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.51B3.18$2.53 per share23.32$29.32 per share2.01
Integer Holdings Co. stock logo
ITGR
Integer
$1.75B2.37$7.82 per share15.18$48.27 per share2.46
Teleflex Incorporated stock logo
TFX
Teleflex
$3.01B1.77$12.99 per share9.30$94.49 per share1.28
Synthorx, Inc. stock logo
THOR
Synthorx
N/AN/AN/AN/A$6.72 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.3478.5614.621.614.09%10.83%8.63%8/5/2025 (Estimated)
Integer Holdings Co. stock logo
ITGR
Integer
$90.65M$2.1135.3317.851.726.92%11.65%5.89%7/24/2025 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$356.33M$3.1724.027.961.737.85%14.19%8.53%7/30/2025 (Estimated)
Synthorx, Inc. stock logo
THOR
Synthorx
-$56.61M-$6.59N/AN/AN/AN/A-26.09%-24.62%N/A

Latest THOR, GMED, TFX, and ITGR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.74$0.68-$0.06$0.54$629.74 million$598.12 million
5/1/2025Q1 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$2.88$2.91+$0.03$2.07$699.37 million$700.67 million
4/24/2025Q1 2025
Integer Holdings Co. stock logo
ITGR
Integer
$1.27$1.31+$0.04-$0.66$428.51 million$437.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Integer Holdings Co. stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.13%N/A42.90%N/A
Synthorx, Inc. stock logo
THOR
Synthorx
N/AN/AN/AN/AN/A

Latest THOR, GMED, TFX, and ITGR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/12/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.09%5/20/20255/20/20256/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
2.51
1.64
Integer Holdings Co. stock logo
ITGR
Integer
0.62
2.95
2.09
Teleflex Incorporated stock logo
TFX
Teleflex
0.37
2.42
1.39
Synthorx, Inc. stock logo
THOR
Synthorx
N/A
18.87
18.87

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Integer Holdings Co. stock logo
ITGR
Integer
99.29%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%
Synthorx, Inc. stock logo
THOR
Synthorx
66.12%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.51%
Integer Holdings Co. stock logo
ITGR
Integer
2.16%
Teleflex Incorporated stock logo
TFX
Teleflex
1.40%
Synthorx, Inc. stock logo
THOR
Synthorx
53.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
2,600135.38 million110.92 millionOptionable
Integer Holdings Co. stock logo
ITGR
Integer
10,00034.89 million32.87 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
15,50044.19 million45.78 millionOptionable
Synthorx, Inc. stock logo
THOR
Synthorx
4832.34 millionN/ANot Optionable

Recent News About These Companies

Biosimilar Interleukins Global Market Report 2023

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Globus Medical stock logo

Globus Medical NYSE:GMED

$58.92 +0.02 (+0.03%)
As of 12:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Integer stock logo

Integer NYSE:ITGR

$118.71 +0.41 (+0.35%)
As of 12:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Teleflex stock logo

Teleflex NYSE:TFX

$120.80 +0.87 (+0.72%)
As of 12:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Synthorx stock logo

Synthorx NASDAQ:THOR

Synthorx, Inc., a biopharmaceutical company, focuses on the development of cytokine Synthorin programs for the treatment of cancer and autoimmune disorders in the United States. The company's lead product candidate is THOR-707, a variant of recombinant human IL-2 that is in the development in various solid tumor types as a single agent and in combination with an immune checkpoint inhibitor. It also develops IL-2 Synthorin for autoimmune indications; IL-10 Synthorin, a naturally occurring immune cell growth factor in humans for the treatment of immuno-oncology (IO); and IL-15 Synthorins, an immunoregulatory cytokine to treat IO. In addition, the company develops other Synthorin programs targeting undisclosed cytokines that play critical roles in the orchestration of anti-tumor responses by innate and adaptive immune cells. The company was formerly known as Alinos, Inc. and changed its name to Synthorx, Inc. in March 2014. Synthorx, Inc. was founded in 2014 and is headquartered in La Jolla, California.